UBI Pharma Inc., established on July 31, 2014, is a trailblazing force in the pharmaceutical industry. We take pride in being the first pharmaceutical company in Asia (excluding Japan) to successfully pass the rigorous US FDA inspection for our injection filling production line. With over two decades of experience in the pharmaceutical sector, we have forged a path dedicated to pioneering long-acting protein drugs and specialized injectables.

Our dedicated team, comprised of nearly 300 professionals, with almost 30% holding master's degrees or higher, operates from our headquarters and state-of-the-art manufacturing center situated in Hsinchu Industrial Park, covering an impressive 240,000 square feet. Additionally, we have strategically established clinical centers and business hubs in Taipei.